Physician profile
Daniel Joseph Hackett
NPI 1306132360
$104,299.37
in general payments reported to CMS, 2019-2025
38 companies · $51K in 2025
The $51K reported for 2025 was more than what 95% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,457 · 2020: $363 · 2021: $1,989 · 2022: $4,827 · 2023: $1,764 · 2024: $40K · 2025: $51K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $68K · Travel and Lodging: $17K · Food and Beverage: $7,394.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $67,783.88 |
| Travel and Lodging | $17,484.73 |
| Food and Beverage | $7,394.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Encore Medical, Lp | $37,305.16 | 2019-2025 | Djo Surgical |
| Medical Device Business Services, INC. | $28,287.74 | 2019-2025 | Inhance, Healix Knotless Peek |
| Depuy Synthes Products, INC. | $11,449.90 | 2021-2025 | Inhance |
| Linvatec Corporation | $10,849.96 | 2019-2025 | Biobrace 23mm, Y-Knot, Livatec Knee Preservation System |
| Smith+Nephew, INC. | $3,347.09 | 2020-2025 | Bone Anchors With Arthroscopic Delivery System, Microraptor, Q-Fix |
| Depuy Synthes Sales INC. | $2,829.58 | 2019-2025 | Inhance, Gryphon Orthocord, Healix Knotless Peek |
| Legacy Ortho LLC | $2,101.41 | 2022-2024 | |
| Cdc Medical LLC | $1,580.00 | 2019 | |
| Insight Medical Systems, INC. | $1,331.89 | 2024 | Arvis |
| Arthrex, INC. | $1,222.10 | 2021-2024 | |
| Stryker Corporation | $1,174.96 | 2022-2025 | Alphavent, Variax, Blueprint Patient Specific Instrumentation |
| Zimmer Biomet Holdings, INC. | $598.50 | 2019-2024 | Comprehensive Shoulder System, Identity |
| Abbott Laboratories | $270.87 | 2023-2024 | Proclaim |
| International Life Sciences | $238.92 | 2024 | Flexband |
| Embody, INC. | $236.11 | 2022 |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $221.15 | 2021-2024 | Exparel |
| Skeletal Dynamics INC | $196.32 | 2022-2024 | Implate, Align, Ijs |
| Blue Surgical LLC | $161.16 | 2024-2025 | |
| Catalyst Orthoscience | $119.42 | 2024-2025 | Catalyst Csr Shoulder System |
| Horizon Therapeutics Plc | $103.17 | 2019-2022 | |
| Restor3d, INC. | $100.00 | 2021 | |
| Anika Therapeutics, INC. | $95.03 | 2024 | Integrity |
| Exactech, INC. | $76.08 | 2020 | |
| Vertex Pharmaceuticals Incorporated | $72.35 | 2025 | |
| Heron Therapeutics, INC. | $54.52 | 2021-2025 | Zynrelef |
| Acumed LLC | $40.63 | 2023 | Acumed |
| Djo, LLC | $38.14 | 2025 | Aircast, Donjoy |
| Carbofix Orthopedics INC | $33.12 | 2023 | |
| Inari Medical, INC. | $29.10 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Fidia Pharma USA INC. | $21.22 | 2024 | Hyalgan, Hymovis, Triluron |
| Xiros INC | $19.29 | 2022 | |
| Shoulder Innovations, INC. | $17.81 | 2025 | Inset System |
| Convatec INC. | $17.52 | 2019 | |
| Atricure, INC. | $16.97 | 2025 | Atricure Cryoice Cryosphere Cryoablation System |
| Organogenesis INC. | $16.52 | 2022 | |
| Amgen INC. | $14.97 | 2025 | Evenity |
| My01 INC. | $10.69 | 2023 | My01 Continuous Compartmental Pressure Monitor |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$250,956.16 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Hackett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.